5
Hemo Organic
HEMOORGANICLTD NSE
Hemo Organic
ServicesNSE: HEMOORGANICLTD BSE: 524590 Commercial Services & Supplies
Key Fundamentals
MicrocapTrading & DistributorsCommercial ServicesMarket Cap
₹6.60 Cr
P/E Ratio
-8.6
EBITDA
₹-0.50 Cr
Return on Equity
-585.48%
Debt to Equity
21.08
Book Value
₹-2.68
52W High
₹24.42
52W Low
₹8.12
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Weaknesses
5- Stock is trading at 50.4 times its book value
- Company has low interest coverage ratio.
- Promoter holding is low: 16.8%
- Company might be capitalizing the interest cost
- Company has high debtors of 938 days.
Growth Rate
Revenue Growth
-64%
Net Income Growth
-500% lower than
3Y
Cash Flow Change
-306% lower than
3Y
ROE
441% higher than
3Y
ROCE
-998% lower than
3Y
EBITDA Margin (Avg.)
—
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | 2.41 | 0 | 0 | 0 | 0.93 | 0 |
| Expenses | 0.04 | -0.01 | 0 | 0.23 | 0 | 0.08 | 0.08 | 2.26 | 0.11 | 0.04 | 0.05 | 1.23 | 0.07 |
| Operating Profit | -0.04 | 0.01 | 0 | -0.21 | 0 | -0.08 | -0.08 | 0.15 | -0.11 | -0.04 | -0.05 | -0.3 | -0.07 |
| OPM % | — | — | — | -1050% | — | — | — | 6.22% | — | — | — | -32.26% | — |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.09 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | -0.04 | 0.01 | 0 | -0.23 | 0 | -0.08 | -0.08 | 0.24 | -0.11 | -0.04 | -0.05 | -0.3 | -0.07 |
| Tax % | 0% | 0% | — | 0% | — | 0% | 0% | -58.33% | -27.27% | -25% | 220% | 70% | 0% |
| Net Profit | -0.04 | 0.01 | 0 | -0.23 | 0 | -0.08 | -0.08 | 0.37 | -0.09 | -0.03 | -0.16 | -0.51 | -0.07 |
| EPS in Rs | -0.12 | 0.03 | 0 | -0.66 | 0 | -0.23 | -0.23 | 1.07 | -0.26 | -0.09 | -0.46 | -1.47 | -0.2 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.16 | 0.11 | 0.6 | 0.09 | 0.05 | 0.27 | 0.01 | 0.01 | 0 | 0.02 | 2.41 | 0.93 | 0.93 |
| Expenses | 0.22 | 0.16 | 0.68 | 0.24 | 0.17 | 0.29 | 0.06 | 0.07 | 0.05 | 0.26 | 2.45 | 1.43 | 1.39 |
| Operating Profit | -0.06 | -0.05 | -0.08 | -0.15 | -0.12 | -0.02 | -0.05 | -0.06 | -0.05 | -0.24 | -0.04 | -0.5 | -0.46 |
| OPM % | -37.5% | -45.45% | -13.33% | -166.67% | -240% | -7.41% | -500% | -600% | — | -1200% | -1.66% | -53.76% | -49.46% |
| Other Income | 0.02 | -0.71 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.07 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 |
| Depreciation | 0.07 | 0.06 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | -0.11 | -0.82 | -0.08 | -0.15 | -0.12 | -0.02 | -0.05 | -0.06 | -0.05 | -0.26 | 0.03 | -0.5 | -0.46 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -466.67% | 56% | — |
| Net Profit | -0.11 | -0.82 | -0.08 | -0.15 | -0.12 | -0.02 | -0.05 | -0.06 | -0.05 | -0.26 | 0.16 | -0.78 | -0.77 |
| EPS in Rs | -0.32 | -2.37 | -0.23 | -0.43 | -0.35 | -0.06 | -0.14 | -0.17 | -0.14 | -0.75 | 0.46 | -2.25 | -2.22 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.4 | 3.4 | 3.47 | 3.47 | 3.47 | 3.47 | 3.47 | 3.47 | 3.47 | 3.47 | 3.47 | 3.47 |
| Reserves | -2.16 | -2.98 | -3.06 | -3.21 | -3.33 | -3.35 | -3.4 | -3.46 | -3.52 | -3.78 | -3.62 | -3.34 |
| Borrowings | 0.05 | 0 | 0 | 0.08 | 0.08 | 0 | 0.04 | 0.04 | 0.04 | 1.24 | 1.48 | 2.74 |
| Other Liabilities | 0.08 | 0.11 | 0.72 | 0.66 | 0.73 | 0.13 | 0.12 | 0.19 | 0.35 | 0.13 | 3.65 | 1.59 |
| Total Liabilities | 1.37 | 0.53 | 1.13 | 1 | 0.95 | 0.25 | 0.23 | 0.24 | 0.34 | 1.06 | 4.98 | 4.46 |
| Fixed Assets | 0.92 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0.45 | 0.53 | 1.13 | 1 | 0.95 | 0.25 | 0.23 | 0.24 | 0.34 | 1.06 | 4.98 | 4.46 |
| Total Assets | 1.37 | 0.53 | 1.13 | 1 | 0.95 | 0.25 | 0.23 | 0.24 | 0.34 | 1.06 | 4.98 | 4.46 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 0.06 | -0.78 | -0.15 | -0.12 | -0.04 | 0.01 | -0.01 | 0 | 0.11 | -1.19 | -0.36 | -1.46 |
| Investing | 0 | 0.7 | 0.02 | 0.06 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | -0.86 |
| Financing | 0 | 0.08 | 0.15 | 0 | 0 | 0 | 0 | 0 | 0 | 1.2 | 0.24 | 2.32 |
| Net Cash Flow | 0.07 | 0 | 0.01 | -0.06 | -0.01 | 0.01 | -0.01 | 0 | 0.11 | 0.01 | -0.12 | 0 |
| Free Cash Flow | 0.06 | -0.07 | -0.15 | -0.12 | -0.04 | 0.01 | -0.01 | 0 | 0.11 | -1.19 | -0.36 | -1.46 |
| CFO/OP | -67 | 1,560 | 188 | 80 | 33 | -50 | 20 | 0 | -220 | 496 | 900 | 292 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 342 | 0 | 438 | 2,920 | 5,402 | 94.63 | 2,555 | 2,190 | — | 1,460 | 382 | 938 |
| Inventory Days | 0 | 0 | 20.66 | 91.25 | 0 | 0 | 0 | 730 | — | — | 143 | — |
| Days Payable | — | — | 393 | 3,011 | — | — | — | 4,015 | — | — | 366 | — |
| Cash Conversion Cycle | 342 | 0 | 66.11 | 0 | 5,402 | 94.63 | 2,555 | -1,095 | — | 1,460 | 159 | 938 |
| Working Capital Days | 114 | 232 | 146 | 689 | 438 | -67.59 | -1,825 | -4,015 | — | 11,863 | 156 | 1,122 |
| ROCE % | -7.8% | -12.87% | -19.28% | -40% | -42.86% | -11.76% | -43.48% | -75% | -250% | -52.17% | 2.65% | -23.81% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Hemo Organic insights
56 extracted metrics + investor summaries across FY10–FY26.
Documents
1
Non-Applicability Of SEBI Circular SEBI/HO/DDHS/DDHS RACPOD1/P/CIR/2023/172October19, 2023 - Initial Disclosure For Large Corporate Entity For F.Y. 2026-27.
30 Apr - Hemo Organic confirms it is not a Large Corporate for FY 2026-27. 30 Apr - Hemo Organic confirms it is not a Large Corporate for FY 2026-27.
2
Non-Applicability Of SEBI Circular SEBI/HO/DDHS/DDHS RACPOD1/P/CIR/2023/172October19, 2023 - Initial Disclosure For Large Corporate Entity For F.Y. 2026-27.
30 Apr - Hemo Organic confirms it is not a Large Corporate for FY 2026-27. 30 Apr - Hemo Organic confirms it is not a Large Corporate for FY 2026-27.
3
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
9 Apr - Submission of Certificate under Reg 74 (5) of the SEBI (DP) Regulations, 2018 for the Quarter ended 31 March, 2026 9 Apr - Submission of Certificate under Reg 74 (5) of the SEBI (DP) Regulations, 2018 for the Quarter ended 31 March, 2026
4
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E., Tuesday, 31St March, 2026
31 Mar - Independent director Deepak Rochani resigned effective 31 Mar 2026; committees reconstituted effective 1 Apr 2026. 31 Mar - Independent director Deepak Rochani resigned effective 31 Mar 2026; committees reconstituted effective 1 Apr 2026.
5
Announcement under Regulation 30 (LODR)-Change in Management
31 Mar - Deepak Ashokkumar Rochani resigned as Independent Director effective 31 March 2026; left all committees. 31 Mar - Deepak Ashokkumar Rochani resigned as Independent Director effective 31 March 2026; left all committees.
1
Board Meeting Outcome for Outcome Of The Board Meeting Held Toady I.E. Wednesday 9Th September 2026. 9 Sept 2026
Outcome
Frequently Asked Questions about Hemo Organic
What does Hemo Organic Ltd do?
Incorporated in 1992, Hemo Organic Ltd is in the business of trading & distribution of Rice and Textiles.
Where is Hemo Organic Ltd (524590) listed?
Hemo Organic Ltd trades as HEMOORGANICLTD on the NSE and under code 524590 on the BSE.
Which sector does Hemo Organic Ltd belong to?
Hemo Organic Ltd is classified under the Services sector, in the Commercial Services & Supplies industry.
What is the market capitalisation of Hemo Organic Ltd?
Hemo Organic Ltd has a market capitalisation of ₹6.6 Cr, which places it in the Small Cap band.
What is the PE ratio of Hemo Organic Ltd?
Hemo Organic Ltd trades at a PE ratio of -8.60, against a book value of ₹-2.68 per share.
What is the 52-week high and low of Hemo Organic Ltd?
Over the last 52 weeks Hemo Organic Ltd has traded between ₹8.12 and ₹24.42.
What is the Return on Equity (ROE) of Hemo Organic Ltd?
Hemo Organic Ltd reported a return on equity of -585.48%. Its debt-to-equity ratio is 21.08.
Company Information
Incorporated in 1992, Hemo Organic Ltd is in the business of trading & distribution of Rice and Textiles.
Website hemoorganicltd.com
Face Value ₹ 10
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524590.md for Hemo Organic Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.